Author Archives: Natalie Themm
IDbyDNA Improves Analytical Performance and User Experience of Its Explify Platform and Respiratory and Urinary Pathogen ID/AMR Panels
IDbyDNA develops Precision Metagenomic solutions with faster, comprehensive pathogen identification, quantification, and profiling powered by AI-driven genomic analysis and next-generation sequencing.
Biotech Perfect Day opens Location in BioHive Hub
The Gateway, a growing campus for life sciences companies, will expand and diversify the footprint of Perfect Day’s technology capabilities and teams
Thermo Fisher Scientific Expands in Utah with New Bioprocessing Manufacturing Site in Ogden
Company now employs more than 2,000 people state-wide across three locations
Merit Medical Receives FDA Clearance for SCOUT Bx™ Delivery System
New technology is designed to allow physicians to place SCOUT® reflector at time of biopsy for breast localization under stereotactic and MRI guidance
Merit Medical Receives FDA “Breakthrough Device Designation” for Embosphere® Microspheres for Use in Genicular Artery Embolization for Symptomatic Knee Osteoarthritis
SOUTH JORDAN, Utah, March 07, 2022 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), announced today that it has received “breakthrough device designation” from the U.S. Food & Drug Administration (FDA) for Embosphere® Microspheres for the Genicular Artery Embolization (GAE) indication. GAE is a procedure intended to reduce pain and disability caused by knee osteoarthritis by […]
Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Hepatitis C Viral Load Test
Co-Diagnostics announced that CoSara Diagnostics has received clearance by the CDSCO in India to manufacture and sell its SARAQ™ Hepatitis C Viral Load Kit as an in vitro diagnostic.
2022 Medical Design Excellence Awards Winners: Radiological, Imaging, and Electromechanical Devices
Turner Imaging’s SmartC was recently recognized as a 2022 Medical Design Excellence Award Winner by the Medical Device and Diagnostics Industry QMed.
Forbes Recognizes Recursion as a Best Startup Employer
Congratulations to the Recursion team and CEO Chris Gibson on making the Forbes’ list of America’s Best Startup Employers for 2022.
Alucent Biomedical Announces First Patient Enrolled in First in Human Natural Vascular Scaffolding Clinical Trial
Multicenter ACTIVATE II Study to Enroll up to 50 Patients in Australia
Inherent Biosciences awarded NIH SBIR Phase I Grant to commercialize innovative diagnosis of non-obstructive azoospermia (the most severe form of sperm dysfunction)
Inherent Biosciences announced an award from the National Institute of Child Health and Human Development’s Fertility and Infertility Branch to develop a clinical assay for improved diagnosis of non-obstructive azoospermia (NOA).
Recursion is Granted Fast Track Designation for REC-4881 for the Potential Treatment of Familial Adenomatous Polyposis
Recursion is Granted Fast Track Designation for REC-4881 for the Potential Treatment of Familial Adenomatous Polyposis
FDA Clears Four New Coronary Micro Support Catheters
Non-tapered metal-alloy support catheter platform receives FDA clearance for use in coronary and peripheral vasculature.
